nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—Melatonin—MTNR1B—polycystic ovary syndrome	0.0191	0.68	CrCbGaD
Rizatriptan—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00969	0.0564	CcSEcCtD
Rizatriptan—Ear pain—Metformin—polycystic ovary syndrome	0.00668	0.0389	CcSEcCtD
Rizatriptan—Dehydration—Metformin—polycystic ovary syndrome	0.0053	0.0308	CcSEcCtD
Rizatriptan—Melatonin—CYP19A1—polycystic ovary syndrome	0.00518	0.185	CrCbGaD
Rizatriptan—Cramp muscle—Metformin—polycystic ovary syndrome	0.00513	0.0299	CcSEcCtD
Rizatriptan—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0051	0.0297	CcSEcCtD
Rizatriptan—Abdominal distension—Metformin—polycystic ovary syndrome	0.00496	0.0289	CcSEcCtD
Rizatriptan—Angina pectoris—Metformin—polycystic ovary syndrome	0.0048	0.0279	CcSEcCtD
Rizatriptan—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00472	0.0275	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00458	0.0266	CcSEcCtD
Rizatriptan—Bradycardia—Metformin—polycystic ovary syndrome	0.00401	0.0234	CcSEcCtD
Rizatriptan—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00392	0.0228	CcSEcCtD
Rizatriptan—Melatonin—CYP1A1—polycystic ovary syndrome	0.00381	0.136	CrCbGaD
Rizatriptan—Flushing—Metformin—polycystic ovary syndrome	0.00366	0.0213	CcSEcCtD
Rizatriptan—Angiopathy—Metformin—polycystic ovary syndrome	0.00358	0.0208	CcSEcCtD
Rizatriptan—Chills—Metformin—polycystic ovary syndrome	0.00354	0.0206	CcSEcCtD
Rizatriptan—Erythema—Metformin—polycystic ovary syndrome	0.00343	0.02	CcSEcCtD
Rizatriptan—Flatulence—Metformin—polycystic ovary syndrome	0.00338	0.0197	CcSEcCtD
Rizatriptan—Dysgeusia—Metformin—polycystic ovary syndrome	0.00336	0.0196	CcSEcCtD
Rizatriptan—Muscle spasms—Metformin—polycystic ovary syndrome	0.0033	0.0192	CcSEcCtD
Rizatriptan—Vision blurred—Metformin—polycystic ovary syndrome	0.00323	0.0188	CcSEcCtD
Rizatriptan—Tremor—Metformin—polycystic ovary syndrome	0.00321	0.0187	CcSEcCtD
Rizatriptan—Syncope—Metformin—polycystic ovary syndrome	0.00308	0.0179	CcSEcCtD
Rizatriptan—Palpitations—Metformin—polycystic ovary syndrome	0.00303	0.0177	CcSEcCtD
Rizatriptan—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00302	0.0176	CcSEcCtD
Rizatriptan—Hypertension—Metformin—polycystic ovary syndrome	0.00296	0.0172	CcSEcCtD
Rizatriptan—Chest pain—Metformin—polycystic ovary syndrome	0.00292	0.017	CcSEcCtD
Rizatriptan—Myalgia—Metformin—polycystic ovary syndrome	0.00292	0.017	CcSEcCtD
Rizatriptan—Discomfort—Metformin—polycystic ovary syndrome	0.00289	0.0168	CcSEcCtD
Rizatriptan—Oedema—Metformin—polycystic ovary syndrome	0.0028	0.0163	CcSEcCtD
Rizatriptan—Shock—Metformin—polycystic ovary syndrome	0.00276	0.016	CcSEcCtD
Rizatriptan—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00275	0.016	CcSEcCtD
Rizatriptan—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00271	0.0158	CcSEcCtD
Rizatriptan—Anorexia—Metformin—polycystic ovary syndrome	0.00267	0.0155	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00255	0.0149	CcSEcCtD
Rizatriptan—Paraesthesia—Metformin—polycystic ovary syndrome	0.00251	0.0146	CcSEcCtD
Rizatriptan—Dyspnoea—Metformin—polycystic ovary syndrome	0.0025	0.0145	CcSEcCtD
Rizatriptan—Somnolence—Metformin—polycystic ovary syndrome	0.00249	0.0145	CcSEcCtD
Rizatriptan—Dyspepsia—Metformin—polycystic ovary syndrome	0.00247	0.0144	CcSEcCtD
Rizatriptan—Decreased appetite—Metformin—polycystic ovary syndrome	0.00243	0.0142	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00242	0.0141	CcSEcCtD
Rizatriptan—Fatigue—Metformin—polycystic ovary syndrome	0.00241	0.0141	CcSEcCtD
Rizatriptan—Constipation—Metformin—polycystic ovary syndrome	0.00239	0.0139	CcSEcCtD
Rizatriptan—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00231	0.0134	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00229	0.0133	CcSEcCtD
Rizatriptan—Urticaria—Metformin—polycystic ovary syndrome	0.00222	0.013	CcSEcCtD
Rizatriptan—Abdominal pain—Metformin—polycystic ovary syndrome	0.00221	0.0129	CcSEcCtD
Rizatriptan—Asthenia—Metformin—polycystic ovary syndrome	0.00201	0.0117	CcSEcCtD
Rizatriptan—Pruritus—Metformin—polycystic ovary syndrome	0.00198	0.0115	CcSEcCtD
Rizatriptan—Diarrhoea—Metformin—polycystic ovary syndrome	0.00192	0.0112	CcSEcCtD
Rizatriptan—Dizziness—Metformin—polycystic ovary syndrome	0.00185	0.0108	CcSEcCtD
Rizatriptan—Vomiting—Metformin—polycystic ovary syndrome	0.00178	0.0104	CcSEcCtD
Rizatriptan—Rash—Metformin—polycystic ovary syndrome	0.00177	0.0103	CcSEcCtD
Rizatriptan—Dermatitis—Metformin—polycystic ovary syndrome	0.00176	0.0103	CcSEcCtD
Rizatriptan—Headache—Metformin—polycystic ovary syndrome	0.00175	0.0102	CcSEcCtD
Rizatriptan—Nausea—Metformin—polycystic ovary syndrome	0.00166	0.00968	CcSEcCtD
Rizatriptan—HTR1D—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000292	0.000364	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000291	0.000363	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00029	0.000363	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000289	0.000362	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PGR—polycystic ovary syndrome	0.000288	0.000359	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000286	0.000357	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000285	0.000357	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000284	0.000355	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000283	0.000354	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00028	0.00035	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000276	0.000344	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000274	0.000343	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000272	0.00034	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—LHB—polycystic ovary syndrome	0.000272	0.00034	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000268	0.000335	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000268	0.000335	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000267	0.000334	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000267	0.000334	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000267	0.000333	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—HSD3B2—polycystic ovary syndrome	0.000266	0.000332	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FST—polycystic ovary syndrome	0.000265	0.000332	CbGpPWpGaD
Rizatriptan—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000265	0.000331	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000264	0.00033	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000262	0.000328	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000261	0.000326	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FST—polycystic ovary syndrome	0.00026	0.000325	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—LHB—polycystic ovary syndrome	0.000259	0.000324	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000258	0.000323	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000258	0.000322	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AKR1C1—polycystic ovary syndrome	0.000257	0.000322	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000257	0.000321	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000255	0.000319	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000255	0.000318	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—LHB—polycystic ovary syndrome	0.000254	0.000317	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000253	0.000316	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000249	0.000311	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000248	0.00031	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000248	0.000309	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000247	0.000308	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000245	0.000306	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000245	0.000306	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000244	0.000305	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SCT—polycystic ovary syndrome	0.000243	0.000303	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00024	0.0003	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00024	0.000299	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00024	0.000299	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000238	0.000297	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SCT—polycystic ovary syndrome	0.000238	0.000297	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—SULT2A1—polycystic ovary syndrome	0.000237	0.000296	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000236	0.000295	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000235	0.000294	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000235	0.000293	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000234	0.000292	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PRL—polycystic ovary syndrome	0.000233	0.000292	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000232	0.000289	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—RRM2—polycystic ovary syndrome	0.000229	0.000287	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000228	0.000284	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000227	0.000283	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000226	0.000282	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000225	0.000281	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000225	0.000281	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000223	0.000278	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000222	0.000278	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000222	0.000278	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000221	0.000277	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—YAP1—polycystic ovary syndrome	0.000221	0.000276	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000221	0.000276	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00022	0.000275	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000218	0.000272	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000217	0.000272	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000217	0.000271	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000216	0.00027	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000216	0.00027	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000216	0.00027	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000213	0.000266	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—NAMPT—polycystic ovary syndrome	0.000212	0.000265	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000211	0.000263	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP11A1—polycystic ovary syndrome	0.00021	0.000262	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000209	0.000261	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000208	0.00026	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000206	0.000258	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000205	0.000257	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000203	0.000254	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000203	0.000254	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000201	0.000251	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.0002	0.00025	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—INSR—polycystic ovary syndrome	0.000199	0.000248	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AKR1C3—polycystic ovary syndrome	0.000198	0.000248	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FST—polycystic ovary syndrome	0.000198	0.000247	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000197	0.000246	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000196	0.000245	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000196	0.000244	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000196	0.000244	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP17A1—polycystic ovary syndrome	0.000195	0.000244	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—INSR—polycystic ovary syndrome	0.000195	0.000243	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000193	0.000241	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000192	0.00024	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000189	0.000236	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000189	0.000236	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000186	0.000232	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000185	0.000231	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PGR—polycystic ovary syndrome	0.000184	0.00023	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000183	0.000229	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000183	0.000229	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000183	0.000228	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000182	0.000227	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000181	0.000226	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PGR—polycystic ovary syndrome	0.00018	0.000225	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000179	0.000223	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000174	0.000217	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000173	0.000216	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000171	0.000214	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000171	0.000214	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000171	0.000213	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000171	0.000213	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00017	0.000212	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—TH—polycystic ovary syndrome	0.000169	0.000211	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000168	0.00021	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000167	0.000209	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000167	0.000209	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000166	0.000207	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000165	0.000206	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000164	0.000205	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—SLC2A4—polycystic ovary syndrome	0.000164	0.000205	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000164	0.000205	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000163	0.000204	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000161	0.000202	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000161	0.000202	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—LEP—polycystic ovary syndrome	0.000161	0.000201	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00016	0.0002	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000159	0.000199	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000158	0.000198	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000157	0.000196	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000156	0.000195	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000155	0.000194	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000155	0.000194	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP19A1—polycystic ovary syndrome	0.000154	0.000193	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000151	0.000188	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00015	0.000187	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PRL—polycystic ovary syndrome	0.000149	0.000186	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000148	0.000185	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000147	0.000184	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000146	0.000183	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PRL—polycystic ovary syndrome	0.000146	0.000183	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000144	0.00018	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000144	0.000179	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000143	0.000179	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000142	0.000177	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000141	0.000176	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000141	0.000176	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000139	0.000173	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000139	0.000173	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—POMC—polycystic ovary syndrome	0.000138	0.000173	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GNAS—polycystic ovary syndrome	0.000138	0.000172	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—INS—polycystic ovary syndrome	0.000137	0.000172	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000137	0.000171	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000136	0.000169	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000133	0.000166	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000133	0.000166	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000131	0.000164	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—NCOR1—polycystic ovary syndrome	0.000131	0.000164	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000129	0.000162	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000129	0.000161	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000128	0.00016	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000128	0.000159	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000128	0.000159	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000126	0.000158	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000125	0.000156	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP1A1—polycystic ovary syndrome	0.000124	0.000155	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000123	0.000154	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000123	0.000153	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000122	0.000153	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000122	0.000152	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00012	0.00015	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000119	0.000148	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000118	0.000148	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—MTHFR—polycystic ovary syndrome	0.000116	0.000145	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	0.000115	0.000144	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000112	0.00014	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000112	0.000139	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000111	0.000139	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.00011	0.000137	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000109	0.000136	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000107	0.000134	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000106	0.000132	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000105	0.000131	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000103	0.000129	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000103	0.000129	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—LEP—polycystic ovary syndrome	0.000103	0.000129	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000102	0.000127	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—LEP—polycystic ovary syndrome	0.000101	0.000126	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	0.0001	0.000125	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	9.8e-05	0.000122	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	9.79e-05	0.000122	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	9.49e-05	0.000119	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PPARG—polycystic ovary syndrome	9.4e-05	0.000118	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.33e-05	0.000117	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—POMC—polycystic ovary syndrome	9.27e-05	0.000116	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—INS—polycystic ovary syndrome	9.22e-05	0.000115	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IRS1—polycystic ovary syndrome	9.18e-05	0.000115	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	9.15e-05	0.000114	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IRS1—polycystic ovary syndrome	8.99e-05	0.000112	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—POMC—polycystic ovary syndrome	8.84e-05	0.00011	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—INS—polycystic ovary syndrome	8.79e-05	0.00011	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	8.73e-05	0.000109	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.68e-05	0.000109	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—POMC—polycystic ovary syndrome	8.65e-05	0.000108	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—INS—polycystic ovary syndrome	8.61e-05	0.000108	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF1—polycystic ovary syndrome	8.5e-05	0.000106	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT2—polycystic ovary syndrome	8.49e-05	0.000106	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	8.46e-05	0.000106	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF1—polycystic ovary syndrome	8.32e-05	0.000104	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT2—polycystic ovary syndrome	8.32e-05	0.000104	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	8.15e-05	0.000102	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.07e-05	0.000101	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.9e-05	9.88e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	7.84e-05	9.8e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	7.83e-05	9.79e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.79e-05	9.73e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	7.74e-05	9.67e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.68e-05	9.6e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	7.67e-05	9.59e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	7.31e-05	9.13e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	7.19e-05	8.99e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	6.85e-05	8.56e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	6.59e-05	8.24e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	6.56e-05	8.19e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6—polycystic ovary syndrome	6.5e-05	8.12e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6—polycystic ovary syndrome	6.37e-05	7.96e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	6.34e-05	7.92e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	6.34e-05	7.92e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TH—polycystic ovary syndrome	6.22e-05	7.78e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	6.05e-05	7.57e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.02e-05	7.53e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6—polycystic ovary syndrome	6.01e-05	7.51e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	5.69e-05	7.11e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.55e-05	6.94e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.44e-05	6.79e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	5.08e-05	6.35e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.85e-05	6.06e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	4.84e-05	6.05e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	4.59e-05	5.73e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	4.28e-05	5.35e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.14e-05	5.18e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6—polycystic ovary syndrome	3.84e-05	4.8e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6—polycystic ovary syndrome	3.76e-05	4.7e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	3.47e-05	4.33e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	3.42e-05	4.27e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—INS—polycystic ovary syndrome	3.4e-05	4.25e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	2.86e-05	3.58e-05	CbGpPWpGaD
